• Ada, G. and Ramshaw, I., DNA vaccination.Expert Opin. Emerg. Drugs, 8, 27–35 (2003).

  Article PubMed CAS  Google Scholar 

• Adachi, J. A., D’Alessio, F. R., and Ericsson, C. D., Reactive arthritis associated with typhoid vaccination in travelers: report of two cases with negative HLA-B27.J. Travel Med., 7, 35–36 (2000).

  PubMed CAS  Google Scholar 

• Amorij, J. P., Meulenaar, J., Hinrichs, W. L., Stegmann, T., Huckriede, A., Coenen, F., and Frijlink, H. W., Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying.Vaccine, 25, 6447–6457 (2007).

  Article PubMed CAS  Google Scholar 

• Andre, F. E., Development and clinical application of new polyvalent combined peadiatric vaccines.Vaccine, 26, 1620–1627 (1999).

  Article  Google Scholar 

• Audsley, J. M. and Tannock, G. A., Cell-based influenza vaccines: progress to date.Drugs, 68, 1483–1491 (2008).

  Article PubMed  Google Scholar 

• Audsley, J. M. and Tannock, G. A., The role of cell culture vaccines in the control of the next influenza pandemic.Expert Opin. Biol. Ther., 4, 709–717 (2004).

  Article PubMed CAS  Google Scholar 

• Bachmayer, H. and Wagner, K., Characterization of recent influenza A variants. I. Biochemical studies.Arch. Gesamte Virusforsch., 42, 177–181 (1973).

  Article PubMed CAS  Google Scholar 

• Bae, C. S. (Bae, K. D.), Lim, G. Y., Kim, J. S., and Hur, B. K., Quadrivalent combined vaccine including diphtheria toxoid, tetanus toxoid, detoxified whole cell pertussis, and hepatitis B surface antigen.J. Microbiol. Biotechnol., 13, 338–343 (2003).

  CAS  Google Scholar 

• Bae, C. S. (Bae, K. D.), Park, K. N., Ahn, S. J., Kim, J. S., and Hur, B. K., Development of a quadrivalent combined DTaP-HepB vaccine with a low toxicity and a stable HBsAg immunogenicity.J. Microbiol. Biotechnol., 12, 787–792 (2002).

  Google Scholar 

• Barry, M. and Cooper, C., Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy.Expert Opin. Biol. Ther., 7, 1731–1737 (2007).

  Article PubMed CAS  Google Scholar 

• Belshe, R. B., Current status of live attenuated influenza virus vaccine in the US.Virus Res. 103, 177–185 (2004).

  Article PubMed CAS  Google Scholar 

• Bernstein, D. I., A live attenuated human rotavirus vaccine.Drugs Today, 43, 281–291 (2007).

  Article PubMed  Google Scholar 

• Biedzka-Sarek, M. and El Skurnik, M., How to outwit the enemy: dendritic cells face Salmonella.APMIS, 114, 589–600 (2006).

  Article PubMed CAS  Google Scholar 

• Black, W. J., Munoz, J. J., Peacock, M. G., Schad, P. A., Cowell, J. L., Burchall, J. J., Lim, M., Kent, A., Steinman, L., and Falkow, S., ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis.Science, 240, 656–659 (1988).

  Article PubMed CAS  Google Scholar 

• Blumberg, B. S., Gerstley, B. J., Hungerford, D. A., London, W. T., and Sutnick, A. I., A serum antigen (Australia antigen) in Down’s syndrome, leukemia, and hepatitis.Ann. Intern. Med., 66, 924–931 (1967).

  PubMed CAS  Google Scholar 

• Brusic, V., August, J. T., and Petrovsky N., Information technologies for vaccine research.Expert Rev. Vaccines, 4, 407–417 (2005).

  Article PubMed CAS  Google Scholar 

• Bruss, V., Envelopment of the hepatitis B virus nucleocapsid.Virus Res., 106, 199–209 (2004).

  Article PubMed CAS  Google Scholar 

• Burnette, W. N., Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.Behring Inst. Mitt., 98, 434–441 (1997).

  PubMed CAS  Google Scholar 

• Casey, J. R. and Pichichero, M. E., Acellular pertussis vaccine safety and efficacy in children, adolescents and adults.Drugs, 65, 1367–1389 (2005).

  Article PubMed CAS  Google Scholar 

• Chen, M. W., Cheng, T. J., Huang, Y., Jan, J. T., Ma, S. H., Yu, A. L., Wong, C. H., Ho, D. D., A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses.Proc. Natl. Acad. Sci. U.S.A., 105, 13538–13543 (2008).

  Article PubMed CAS  Google Scholar 

• Cho, H. J., Takabayashi, K., Cheng. P. M., Nguyen, M. D., Corr, M., Tuck, S., and Raz, E., Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism.Nat. Biotechnol. 18, 509–514 (2000).

  Article PubMed CAS  Google Scholar 

• Cintra, O. A. and Rey, L. C., Safety, immunogenicity and efficacy of influenza vaccine in children.J. Pediatr., 82, 83–90 (2006).

  Google Scholar 

• Clements, C. J. and McIntyre, P. B., When science is not enough — a risk/benefit profile of thiomersal-containing vaccines.Expert Opin. Drug Saf., 5, 17–29 (2006).

  Article PubMed CAS  Google Scholar 

• Colacino, J. M. and Staschke, K. A., The identification and development of antiviral agents for the treatment of chronic hepatitis B virus infection.Prog. Drug Res., 50, 259–322 (1998).

  PubMed CAS  Google Scholar 

• Couch, R. B., Advances in influenza virus vaccine research.Ann. N. Y. Acad. Sci., 685, 803–812. (1993).

  Article PubMed CAS  Google Scholar 

• Cusi, M. G., Zurbriggen, R., Correale, P., Valassina, M., Terrosi, C., Pergola, L., Valensin, P. E., and Glück, R., Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.Vaccine, 20, 3436–3442 (2002).

  Article PubMed CAS  Google Scholar 

• Cyr, T., Menzies, A. J., Calver, J., and Whitehouse, L. W., A quantitative analysis for the ADP ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular 140 pertussis vaccine products.Biologicals, 29, 81–95 (2001).

  Article PubMed CAS  Google Scholar 

• Desombere, I., Van der Wielen, M., Van Damme, P., Stoffel, M., De Clercq, N., Goilav, C., and Leroux-Roels, G., Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant.Vaccine, 20, 2597–2602 (2002).

  Article PubMed CAS  Google Scholar 

• de Vries, J. J., Bungener, L., Ter Veer, W., van Alphen, L., van der Ley, P., Wilschut, J., and Huckriede, A., Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity.Vaccine, (2008) [Epub ahead of print].

• Di Fabio, J. L. and de Quadros, C., Considerations for combination vaccine development and use in the developing world.Clin. Infect. Dis., 33(Suppl. 4), S340–S345 (2001).

  Article PubMed  Google Scholar 

• EMEA, Public statement on Triacelluvax; withdrawal of the marketing authorization in the European union. EMEA/15519/02 (2002).

• Engin, A., Influenza type A (H5N1) virus infection.Mikrobiyol. Bul., 41, 485–494 (2007).

  PubMed  Google Scholar 

• Evensen, O., Brudeseth, B., and Mutoloki, S., The vaccine formulation and its role in inflammatory processes in fish—effects and adverse effects.Dev. Biol. (Basel), 121, 117–125 (2005).

  CAS  Google Scholar 

• Faquim-Mauro, E. L. and Macedo, M. S., Induction of IL-4-dependent, anaphylactic-type and IL-4-independent, non-anaphylactic-type IgG1 antibodies is modulated by adjuvants.Int. Immunol., 12, 1733–1740 (2000).

  Article PubMed CAS  Google Scholar 

• Fiers, W., De Filette, M., Birkett, A., Neirynck, S., and Min Jou, W., A “universal” human influenza A vaccine.Virus. Res., 103, 173–176 (2004).

  Article PubMed CAS  Google Scholar 

• Fraser, A., Paul, M., Goldberg, E., Acosta, C. J., and Leibovici, L., Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials.Vaccine, 25, 7848–7857 (2007).

  Article PubMed CAS  Google Scholar 

• Frech, C., Hilbert, A. K., Hartmann, G., Mayer, K., Sauer, T., and Bolgiano, B., Physicochemical analysis of purified diphtheria toxoids: is toxoided then purified the same as purified then toxoided?Dev. Biol., 103, 205–215 (2000).

  CAS  Google Scholar 

• Fukuda, Y., Kokuryu, H., and Imura, H., Diagnosis of type B hepatitisRinsho Byori, 38, 573–577 (1990).

  PubMed CAS  Google Scholar 

• Gentschev, I., Spreng, S., Sieber, H., Ures, J., Mollet, F., Collioud, A., Pearman, J., Griot-Wenk, M. E., Fensterle, J., Rapp, U. R., Goebel, W., Rothen, S. A., and Dietrich, G., Vivotif — a ‘magic shield’ for protection against typhoid fever and delivery of heterologous antigens.Chemotherapy, 53, 177–180 (2007).

  PubMed CAS  Google Scholar 

• Germanier, R. and Füer, E., Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.J. Infect. Dis., 131, 553–558 (1975).

  PubMed CAS  Google Scholar 

• Germanier, R., Vaccination against typhoid fever with a live oral vaccine.Dev. Biol. Stand., 33, 85–88 (1976).

  PubMed CAS  Google Scholar 

• Giannini, S. L., Hanon, E., Moris, P., Van Mechelen, M., Morel, S., Dessy, F., Fourneau, M. A., Colau, B., Suzich, J., Losonksy, G., Martin, M. T., Dubin, G., and Wettendorff, M. A., Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only.Vaccine, 24, 5937–5949 (2006).

  Article PubMed CAS  Google Scholar 

• Gidengil, C. A., Sandora, T. J., and Lee, G. M., Tetanusdiphtheria-acellular pertussis vaccination of adults in the USA.Expert Rev. Vaccines, 7, 621–634 (2008).

  Article PubMed  Google Scholar 

• Gilman, R. H., Hornick, R. B., Woodard, W. E., DuPont, H. L., Snyder, M. J., Levine, M. M., and Libonati, J. P., Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.J. Infect. Dis., 136, 717–723 (1977).

  PubMed CAS  Google Scholar 

• Gomez, S. R., Yuen, C. T., Asokanathan, C., Douglas, B. A., Corbel, M. J., Coote, J. G., Parton, R., and Xing, D. K., ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.Vaccine, 25, 3311–3318 (2007).

  Article PubMed CAS  Google Scholar 

• Granoff, D. M., Correlates of clinical performance of acellular pertussis vaccines: implications for development of DTaP combination vaccines.Biologicals, 27, 87–88 (1999).

  Article PubMed CAS  Google Scholar 

• Greenberg, D. P., Wong, V. K., Partridge, S., chang, S. J., Jing, J., Howe, B. J., and Ward, J. I., Immunogenicity of a haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheriae-tetanusacellular pertussis-hepatitis B comination vaccine.Pediatr. Infect. Dis. J. 19, 1135–1140 (2000).

  Article PubMed CAS  Google Scholar 

• Grumelli, C., Verderio, C., Pozzi, D., Rossetto, O., Montecucco, C., and Matteoli, M., Internalization and mechanism of action of clostridial toxins in neurons.Neurotoxicology, 26, 761–767 (2005).

  Article PubMed CAS  Google Scholar 

• Hamid, N. and Jain, S. K., Immunological, cellular and molecular events in typhoid fever.Indian J. Biochem. Biophys., 44, 320–330 (2007).

  PubMed CAS  Google Scholar 

• Hampson, A. W. and Mackenzie, J. S., The influenza viruses.Med. J. Aust., 185, 39–43 (2006).

  Google Scholar 

• Hatae, K., Kimura, A., Okubo, R., Watanabe, H., Erlich, H. A., Ueda, K., Nishimura, Y., and Sasazuki, T., Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype.Eur. J. Immunol., 22, 1899–1905 (1992).

  Article PubMed CAS  Google Scholar 

• Hardy, E., Martínez, E., Diago, D., Díaz, R., González, D., and Herrera, L., Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris.J. Biotechnol. 77, 157–167 (2000).

  Article PubMed CAS  Google Scholar 

• Hartman, Z. C., Appledorn, D. M., Amalfitano, A., Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications.Virus Res., 132, 1–14 (2008).

  Article PubMed CAS  Google Scholar 

• Heaton, P. M. and Ciarlet, M., Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond.Clin. Infect. Dis., 45, 1618–1624 (2007).

  Article PubMed  Google Scholar 

• Heeg, K. and Dalpke, A., TLR-induced negative regulatory circuits: role of suppressor of cytokine signaling (SOCS) proteins in innate immunity.Vaccine, 21(Suppl. 2), S61–S67 (2003).

  Article PubMed CAS  Google Scholar 

• Heidary, N. and Cohen, D. E., Hypersensitivity reactions to vaccine components.Dermatitis, 16, 115–120 (2005).

  PubMed  Google Scholar 

• Hickman, F. W., Rhoden, D. L., Esaias, A. O., Baron, L. S., Brenner, D. J., and Farmer, J. J. 3rd., Evaluation of two Salmonella typhi strains with reduced virulence for use in teaching and proficiency testing.J. Clin. Microbiol., 15, 1085–1091 (1982).

  PubMed CAS  Google Scholar 

• Hilleman, M. R., Vaccines in historic evolution and perspective: a narrative of vaccine discoveries.Vaccine, 18, 1436–1447 (2000).

  Article PubMed CAS  Google Scholar 

• Horimoto, T. and Kawaoka, Y., Strategies for developing vaccines against H5N1 influenza A viruses.Trends Mol. Med., 12, 506–514 (2006).

  Article PubMed CAS  Google Scholar 

• Iglewski, W. J., Cellular ADP-ribosylation of elongation factor 2.Mol. Cell Biochem., 138, 131–133 (1994).

  Article PubMed CAS  Google Scholar 

• Ivanoff, B., Levine, M. M., and Lambert, P. H., Vaccination against typhoid fever: present status.Bull. World Health Organ., 72, 957–971 (1994).

  PubMed CAS  Google Scholar 

• Jones, B. D. and Falkow, S., Salmonellosis: host immune responses and bacterial virulence determinants.Annu. Rev. Immunol., 14, 533–561 (1996).

  Article PubMed CAS  Google Scholar 

• Ju, C. L., Sheu, G. C., Cheng, Y., and Lu, C. H., Production and purification of Bordetella pertussis toxin.Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi, 30, 72–83 (1997).

  PubMed CAS  Google Scholar 

• Kaistha, J., Sokhey, J., Singh, S., Kumar, S., John, P. C., and Sharma, N. C., Adjuvant effect of DEAE-dextran and tetanus toxoid on whole cell heat inactivated phenol preserved typhoid vaccine.Indian J. Pathol. Microbiol., 39, 287–292 (1996).

  PubMed CAS  Google Scholar 

• Kandimalla, E. R., Bhagat, L., Li, Y., Yu, D., Wang, D., Cong, Y. P., Song, S. S., Tang, J. X., Sullivan, T., and Agrawal, S., Immunomodulatory oligonucleotides containing a cytosine-phosphate-2′-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.Proc. Natl. Acad. Sci. U.S.A., 102, 6925–6930 (2005).

  Article PubMed CAS  Google Scholar 

• Katayama, S., Oda, K., Ohgitani, T., Hirahara, T., and Shimizu, Y., Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky’s disease virus in mice.Vaccine, 17, 2733–2739 (1999).

  Article PubMed CAS  Google Scholar 

• Klinman, D. M., CpG DNA as a vaccine adjuvant.Expert Rev. Vaccines, 2, 305–315 (2003).

  Article PubMed CAS  Google Scholar 

• Kossaczka, Z., Lin, F. Y., Ho, V. A., Thuy, N. T., Van Bay, P., Thanh, T. C., Khiem, H. B., Trach, D. D., Karpas, A., Hunt, S., Bryla, D. A., Schneerson, R., Robbins, J. B., and Szu, S. C., Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.Infect. Immun., 67, 5806–5810 (1999).

  PubMed CAS  Google Scholar 

• Kulkarni, P. S., Raut, S. K., Patki, P. S., Phadke, M. A., Jadhav, S. S., Kapre, S. V., Dhorje, S. P., and Godse, S. R., Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults.Vaccine, 24, 3457–3460 (2006).

  Article PubMed CAS  Google Scholar 

• Levin, D. M., Wong, K. H., Reynolds, H. Y., Sutton, A., and Northrup, R. S., Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.Infect. Immun., 12, 1290–1294 (1975).

  PubMed CAS  Google Scholar 

• Levine, M. M. and Noriega, F., A review of the current status of enteric vaccines.P. N. G. Med. J., 38, 325–331 (1995).

  PubMed CAS  Google Scholar 

• Levine, M. M., Ferreccio, C., Black, R. E., Tacket, C. O., and Germanier, R., Progress in vaccines against typhoid fever.Rev. Infect. Dis., 11(Suppl. 3), S552–S567 (1989).

  PubMed  Google Scholar 

• Levine, M. M., Tacket, C. O., Herrington, D., Losonsky, G., Murphy, J., and Ferreccio, C., The current status of typhoid vaccine development and clinical trials with typhoid vaccines.Southeast Asian J. Trop. Med. Public Health, 19, 459–469 (1988).

  PubMed CAS  Google Scholar 

• Lin, F. Y., Ho, V. A., Khiem, H. B., Trach, D. D., Bay, P. V., Thanh, T. C., Kossaczka, Z., Bryla, D. A., Shiloach, J., Robbins, J. B., Schneerson. R., and Szu, S. C., The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.N. Engl. J. Med., 344, 1263–1269 (2001).

  Article PubMed CAS  Google Scholar 

• Lindberg, A. A., Polyosides (encapsulated bacteria).C. R. Acad. Sci. III, Sci. Vie, 322, 925–932 (1999).

  PubMed CAS  Google Scholar 

• Ljubojeviæ, S., The human papillomavirus vaccines.Acta Dermatovenerol. Croat., 14, 208 (2006).

  Google Scholar 

• Lubran, M. M., Bacterial toxins.Ann. Clin. Lab. Sci., 18, 58–71 (1988).

  PubMed CAS  Google Scholar 

• Maassab, H. F. and Bryant, M. L., The development of live attenuated cold-adapted influenza virus vaccine for humans.Rev. Med. Virol., 9, 237–244 (1999).

  Article PubMed CAS  Google Scholar 

• Mahmood, K., Bright, R. A., Mytle, N., Carter, D. M., Crevar, C. J., Achenbach, J. E., Heaton, P. M., Tumpey, T. M., and Ross, T. M., H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.Vaccine, 26, 5393–5399 (2008).

  Article PubMed CAS  Google Scholar 

• Marshall, G. S., Happe, L. E., Lunacsek, O. E., Szymanski, M. D., Woods, C. R., Zahn, M., and Russell, A., Use of combination vaccines is associated with improved coverage rates.Pediatr. Infect. Dis. J., 26, 496–500 (2007).

  Article PubMed  Google Scholar 

• Marshall, J. D., Fearon, K., Abbate, C., Subramanian, S., Yee, P., Gregorio, J., Coffman, R. L., and Van Nest, G., Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions.J. Leukoc. Biol., 73, 781–792 (2003).

  Article PubMed CAS  Google Scholar 

• Matheson, A. J. and Goa, K. L., Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.Paediatr. Drugs, 2, 139–159 (2000).

  Article PubMed CAS  Google Scholar 

• Matson, D. O., The pentavalent rotavirus vaccine, RotaTeq.Semin. Pediatr. Infect. Dis., 17, 195–199 (2006).

  Article PubMed  Google Scholar 

• McElrath, M. J., Selection of potent immunological adjuvants for vaccine construction.Semin. Cancer Biol. 6, 375–385 (1995).

  Article PubMed CAS  Google Scholar 

• McLemore, M. R., Gardasil: Introducing the new human papillomavirus vaccine.Clin. J. Oncol. Nurs., 10, 559–560 (2006).

  Article PubMed  Google Scholar 

• Meyer, B. K., Ni, A., Hu, B., and Shi, L., Antimicrobial preservative use in parenteral products: past and present.J. Pharm. Sci., 96, 3155–3167 (2007).

  Article PubMed CAS  Google Scholar 

• Milstien, J., Munira, S. L., and McKinney, S. L., Issues in selection of DTwP-based combination vaccines.Vaccine, 21, 1658–1664 (2003).

  Article PubMed CAS  Google Scholar 

• Moravec, T., Schmidt, M. A., Herman, E. M., and Woodford-Thomas, T., Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.Vaccine, 25, 1647–1657 (2007).

  Article PubMed CAS  Google Scholar 

• Morrison, W. I., Taylor, G., Gaddum, R. M., and Ellis, S. A., Contribution of advances in immunology to vaccine development.Adv. Vet. Med., 41, 181–195 (1999).

  Article PubMed CAS  Google Scholar 

• Myint, K. S. and Gibbons, R. V., Hepatitis E: a neglected threat.Trans. R. Soc. Trop. Med. Hyg., 102, 211–212 (2008).

  Article PubMed  Google Scholar 

• Neirynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Jou, W. M., and Fiers, W., A universal influenza A vaccine based on the extracellular domain of the M2 protein.Nat. Med., 5, 1157–1163 (1999).

  Article PubMed CAS  Google Scholar 

• O’Hagan, D. T., Ott, G. S., and Van Nest, G., Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles.Mol. Med. Today, 3, 69–75 (1997).

  Article PubMed  Google Scholar 

• O’Ryan, M., Rotarix (RIX4414): an oral human rotavirus vaccine.Expert Rev. Vaccines, 6, 11–19 (2007).

  Article PubMed  Google Scholar 

• Palache, A. M., Brands, R., and van Scharrenburg, G. J., Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs.J. Infect. Dis. 176, 20–23 (1997).

  Article  Google Scholar 

• Parton, R., Review of the biology ofBordetella pertussis.Biologicals, 27, 71–76 (1999).

  Article PubMed CAS  Google Scholar 

• Pawar, R. D., Patole, P. S., Ellwart, A., Lech, M., Segerer, S., Schlondorff, D., and Anders, H. J., Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis.J. Am. Soc. Nephrol., 17, 3365–3373 (2006).

  Article PubMed CAS  Google Scholar 

• Perentesis, J. P., Miller, S. P., and Bodley, J. W., Protein toxin inhibitors of protein synthesis.Biofactors, 3, 173–184 (1992).

  PubMed CAS  Google Scholar 

• Petrovsky, N. and Aguilar, J. C., Vaccine adjuvants: current state and future trends.Immunol. Cell Biol., 82, 488–496 (2004).

  Article PubMed CAS  Google Scholar 

• Pichichero, M. E. and Stonehocker Quick, L., Clinical evaluation of Pediarix: a new pediatric combination vaccine.Clin. Pediatr. (Phila), 42, 393–400 (2003).

  Article  Google Scholar 

• Pichichero, M. E., Acellular pertussis vaccines. Towards an improved safety profile.Drug Saf., 15, 311–324 (1996).

  Article PubMed CAS  Google Scholar 

• Pichichero, M. E., Bernstein, H., Blatter, M. M., Schuerman, L., Cheuvart, B., and Holmes, S. J., Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.J. Pediatr., 151, 43–49, (2007).

  Article PubMed CAS  Google Scholar 

• Pines, E., Barrand, M., Fabre, P., Salomon, H., Blondeau, C., Wood, S. C., and Hoffenbach, A., New acellular pertussis-containing paediatric combined vaccines.Vaccine, 26, 1650–1656 (1999).

  Article  Google Scholar 

• Plotkin, S. A. and Bouveret-Le Cam, N., A new typhoid vaccine composed of the Vi capsular polysaccharide.Arch. Intern. Med., 155, 2293–2299 (1995).

  Article PubMed CAS  Google Scholar 

• Plotkin, S. A., The effectiveness of whole-cell pertussis vaccines.Dev. Biol. Stand., 89, 171–174 (1997).

  PubMed CAS  Google Scholar 

• Ponvert, C. and Scheinmann, P., Vaccine allergy and pseudo-allergy.Eur. J. Dermatol., 13, 10–15 (2003).

  PubMed  Google Scholar 

• Prescott, S., Developmental immunology and vaccines: cellular immune development and future vaccine strategies.Expert Rev. Vaccines, 3, 339–342 (2004).

  Article PubMed CAS  Google Scholar 

• Raffatellu, M., Chessa, D., Wilson, R. P., Dusold, R., Rubino, S., and Bäumler, A. J., The Vi capsular antigen of Salmonella enterica serotype Typhi reduces Toll-like receptor-dependent interleukin-8 expression in the intestinal mucosa.Infect. Immun., 73, 3367–3374 (2005).

  Article PubMed CAS  Google Scholar 

• Rappuoli, R., Acellular pertussis vaccines: a turning point in infant and adolescent vaccination.Infect. Agents Dis., 5, 21–28 (1996).

  PubMed CAS  Google Scholar 

• Relyveld, E. H., Current developments in production and testing of tetanus and diphtheria vaccines.Prog. Clin. Biol. Res., 47, 51–76 (1980).

  PubMed CAS  Google Scholar 

• Ríhová, B., Immunomodulating activities of soluble synthetic polymer-bound drugs.Adv. Drug Deliv. Rev., 54, 653–674 (2002).

  Article PubMed  Google Scholar 

• Robert, B. B., William, C. G., Paul, M. M., Harshvardhan, B. M., Kutubuddin, M., Keith, R., John, T., Ken, Z., Frederick, G. H., David, I. B., Karen, K., James, K., Pedro, A. P., Stan, L. B., Lihan, Y., and Mark, W., Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.J. Infect. Dis., 181, 1133–1137 (2000).

  Article  Google Scholar 

• Rose, G. W. and Cooper, C. L., Fluarix, inactivated splitvirus influenza vaccine.Expert Opin. Biol. Ther., 6, 301–310 (2006).

  Article PubMed CAS  Google Scholar 

• Safdar, A. and Cox, M. M., Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.Expert Opin. Investig. Drugs, 16, 927–934 (2007).

  Article PubMed CAS  Google Scholar 

• Salehen, N. and Stover, C., The role of complement in the success of vaccination with conjugated vs. unconjugated polysaccharide antigen.Vaccine, 26, 451–459 (2008).

  Article PubMed CAS  Google Scholar 

• Sarkar, S. K. and Pal, S. C., The current status of diarrhoea related vaccines.Indian J. Public Health, 34, 20–34 (1990).

  PubMed CAS  Google Scholar 

• Sato, Y. and Sato, H., Development of acellular pertussis vaccines.Biologicals, 27, 61–69 (1999).

  Article PubMed CAS  Google Scholar 

• Sesardic, D., Dawes, C. S., Mclellan, K., Durrani, Z., Yost, S. E., and Corbel, M. J., Non-pertussis components of combination vaccines: problems with potency testing.Biologicals, 27, 177–181 (1999).

  Article PubMed CAS  Google Scholar 

• Sheu, G. C., Wo, Y. Y., Yao, S. M., Chou, F. Y., Hsu, T. C., Ju, C. L., Cheng, Y., Chang, S. N., and Lu, C. H., Characteristics and potency of an acellular pertussis vaccine composed of pertussis toxin, filamentous hemagglutinin, and pertactin.J. Microbiol. Immunol. Infect., 34, 243–251 (2001).

  PubMed CAS  Google Scholar 

• Slaney, J. M. and Curtis, M. A., Mechanisms of evasion of complement by Porphyromonas gingivalis.Front. Biosci., 13, 188–196 (2008).

  Article PubMed CAS  Google Scholar 

• Soda, K., Sakoda, Y., Isoda, N., Kajihara, M., Haraguchi, Y., Shibuya, H., Yoshida, H., Sasaki, T., Sakamoto, R., Saijo, K., Hagiwara, J., and Kida, H., Development of vaccine strains of H5 and H7 influenza viruses.Jpn. J. Vet. Res., 55, 93–98 (2008).

  PubMed  Google Scholar 

• Stephenne J., Development and production aspects of a recombinant yeast-derived hepatitis B vaccine. Vaccine, 8(Suppl), S69–73 (1990).

  PubMed CAS  Google Scholar 

• Stephenson, I. and Nicholson, K. G., Influenza: vaccination and treatment.Eur. Respir. J. 17, 1282–1293 (2001).

  Article PubMed CAS  Google Scholar 

• Stubi, C. L., Landry, P. R., Pétignat, C., Bille, J., Genton, B., Darioli, R., and Burnier, M., Compliance to live oral Ty21a typhoid vaccine, and its effect on viability.J. Travel Med., 7, 133–137 (2000).

  PubMed CAS  Google Scholar 

• Subramanian, S., Kim, J. J., Harding, F., Altaras, G. M., Aunins, J. G., and Zhou, W., Scaleable production of adenoviral vectors by transfection of adherent PER.C6 cells.Biotechnol. Prog., 23, 1210–1217 (2007).

  PubMed CAS  Google Scholar 

• Swayne, D. E., Application of new vaccine technologies for the control of transboundary diseases.Dev. Biol. (Basel), 119, 219–228 (2004).

  CAS  Google Scholar 

• Szu, S. C., Bystricky, S., Hinojosa-Ahumada, M., Egan, W., and Robbins, J. B., Synthesis and some immunologic properties of anO-acetyl pectin [poly(1→4)-α-D-GalpA]- protein conjugate as a vaccine for typhoid fever.Infect. Immun., 62, 5545–5549 (1994).

  PubMed CAS  Google Scholar 

• Szu, S. C., Taylor, D. N., Trofa, A. C., Clements, J. D., Shiloach, J., Sadoff, J. C., Bryla, D. A., and Robbins, J. B., Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.Infect. Immun., 62, 4440–4444 (1994).

  PubMed CAS  Google Scholar 

• Tai, S. S., Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies.Crit. Rev. Microbiol., 32, 139–153 (2006).

  Article PubMed CAS  Google Scholar 

• Talbot, H. K., Keitel, W., Cate, T. R., Treanor, J., Campbell, J., Brady, R. C., Graham, I., Dekker, C. L., Ho, D., Winokur, P., Walter, E., Bennet, J., Formica, N., Hartel, G., Skeljo, M., and Edwards, K. M., Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.Vaccine, 26, 4057–4061 (2008).

  Article PubMed CAS  Google Scholar 

• Tan, L. U., Fahim, R. E., Jackson, G., Phillips, K., Wah, P., Alkema, D., Zobrist, G., Herbert, A., Boux, L., and Chong, P., A novel process for preparing an acellular pertussis vaccine composed of non-pyrogenic toxoids of pertussis toxin and filamentous hemagglutinin.Mol. Immunol., 28, 251–255 (1991).

  Article PubMed CAS  Google Scholar 

• Taranger, J., Trollfors, B., Bergfors, E., Knutsson, N., Lagergård, T., Schneerson, R., and Robbins, J. B., Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.Pediatrics, 108, E115 (2001).

  Article PubMed CAS  Google Scholar 

• Thierie, J., Modeling threshold phenomena, metabolic pathways switches and signals in chemostat-cultivated cells: the Crabtree effect in Saccharomyces cerevisiae.J. Theor. Biol., 226, 483–501 (2004).

  Article PubMed CAS  Google Scholar 

• Thoelen, S., De Clercq, N., and Tornieporth, N., A prophylactic hepatitis B vaccine with a novel adjuvant system.Vaccine, 19, 2400–2403 (2001).

  Article PubMed CAS  Google Scholar 

• Throsby, M., van den Brink, E., Jongeneelen, M., Poon, L., Alard, P., Cornelissen, L., Bakker, A., Cox, F., van Deventer, E., Guan, Y., Cinatl, J., Meulen, J., Lasters, I., Carsetti, R., Peiris, M., de Kruif, J., and Goudsmit, J., Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM⁺ memory B cells. PLoS ONE, 3, 1–15 (2008).

  Article CAS  Google Scholar 

• Tovar, J. M. and Bazaldua, O. V., New quadrivalent HPV vaccine developments.Postgrad. Med., 120, 14–16 (2008).

  Article PubMed  Google Scholar 

• Tree, J. A., Richardson, C., Fooks, A. R., Clegg, J. C., and Looby, D., Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains.Vaccine, 19, 3444–3450 (2001).

  Article PubMed CAS  Google Scholar 

• Tsai, C. W., Duggan, P. F., Shimp, R. L. Jr., Miller, L. H., and Narum, D. L., Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed inP. pastoris.J. Biotechnol., 121, 458–470 (2006).

  Article PubMed CAS  Google Scholar 

• Ulaeto, D. and Hruby, D. E., Uses of vaccinia virus in vaccine delivery.Curr. Opin. Biotechnol., 5, 501–504 (1994).

  Article PubMed CAS  Google Scholar 

• Varecková, E., Mucha, V., Ciampor, F., Betáková, T., and Russ, G., Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules.Arch. Virol., 130 45–56 (1993).

  Article PubMed  Google Scholar 

• Varecková, E., Mucha, V., Wharton, S. A., and Kostolanský, F., Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.Arch. Virol., 148, 469–486 (2003).

  Article PubMed CAS  Google Scholar 

• Vitek, C. R., Diphtheria.Curr. Top. Microbiol. Immunol., 304, 71–94 (2006).

  Article PubMed CAS  Google Scholar 

• Williams, J. R., Chen, P. Y., Cho, C. T., and Chin, T. D., Influenza: prospect for prevention and control.Kaohsiung J. Med. Sci., 18, 421–434 (2002).

  PubMed  Google Scholar 

• Wilson, R. P., Raffatellu, M., Chessa, D., Winter, S. E., Tükel, C., and Bäumler, A. J., The Vi-capsule prevents Toll-like receptor 4 recognition ofSalmonella.Cell Microbiol., 10, 876–890 (2008).

  Article PubMed CAS  Google Scholar 

• Wintermeyer, S. M., Nahata, M. C., and Kyllonen, K. S., Whole-cell and acellular pertussis vaccines.Ann. Pharmacother., 28, 925–939 (1994).

  PubMed CAS  Google Scholar 

• Wong, K. H., Feeley, J. C., Northrup, R. S., and Forlines, M. E., Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals.Infect. Immun., 9, 348–353 (1974).

  PubMed CAS  Google Scholar 

• Yamada, S., Suzuki, Y., Suzuki, T., Le, M. Q., Nidom, C. A., Sakai-Tagawa, Y., Muramoto, Y., Ito, M., Kiso, M., Horimoto, T., Shinya, K., Sawada, T., Kiso, M., Usui, T., Murata, T., Lin, Y., Hay, A., Haire, L. F., Stevens, D. J., Russell, R. J., Gamblin, S. J., Skehel, J. J., and Kawaoka, Y., Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to humantype receptors.Nature, 444, 378–382 (2006).

  Article PubMed CAS  Google Scholar 

• Yamamoto, S., Yamamoto, T., Nojima, Y., Umemori, K., Phalen, S., McMurray, D. N., Kuramoto, E., Iho, S., Takauji, R., Sato, Y., Yamada, T., Ohara, N., Matsumoto, S., Goto, Y., Matsuo, K., and Tokunaga, T., Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development.Jpn. J. Infect. Dis., 55, 37–44 (2002).

  PubMed CAS  Google Scholar 

• Yokosuka, O. and Arai, M., Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B.Med. Mol. Morphol., 39, 113–120 (2006).

  Article PubMed  Google Scholar 

• Yoo, Y.C., Park, S. Y., Lee, K. B., and Azuma, I., MDP-Lys(L18), a synthetic muramyl dipeptide derivative, enhances antitumor activity of an inactivated tumor vaccine.J. Microbiol. Biotechnol., 10, 399–404 (2000).

  CAS  Google Scholar 

• Zacks, S. I. and Sheff, M. F., Tetanism: pathobiological aspects of the action of tetanal toxin in the nervous system and skeletal mucle.Neurosci. Res., 3, 209–287 (1970).

  CAS  Google Scholar 

• Zambon, M. C., Epidemiology and pathogenesis of influenza.J. Antimicrob. Chemother., 44(Suppl. B), 3–9 (1999).

  Article PubMed CAS  Google Scholar 

• Zhang, X. L., Jeza, V. T., and Pan, Q.,Salmonella typhi: from a human pathogen to a vaccine vector.Cell Mol. Immunol., 5, 91–97 (2008).

  Article PubMed CAS  Google Scholar 

• Zimmerman, R. K., HPV vaccine and its recommendations.J. Fam. Pract., 56(2 Suppl. Vaccines), S1–S5 (2007).

  PubMed  Google Scholar 

Download references